TL;DR
This study identifies circulating microRNA-378 (miR-378) as a potential non-invasive biomarker for coronary artery disease (CAD). They found that lower levels of plasma miR-378 are significantly associated with the severity of coronary artery stenosis, suggesting its utility in assessing disease progression.
What Problem Does This Paper Address?
Coronary artery disease (CAD) is a leading cause of mortality worldwide, and its diagnosis typically relies on invasive procedures like coronary angiography. While there's a need for non-invasive biomarkers to screen for and assess the severity of coronary lesions, few circulating indicators have proven effective. This paper aims to fill that gap by investigating the potential of circulating microRNA-378 (miR-378) as such a biomarker.
Methods
The researchers employed quantitative real-time PCR (qRT-PCR) to measure plasma miR-378 levels in 215 patients diagnosed with CAD and 52 healthy controls. Clinical data, including coronary angiography (CAG) results, were collected. Statistical analyses, such as Spearman's correlation, binary linear regression, and covariance analysis, were used to explore the relationship between miR-378 levels and clinical risk factors. Crucially, Receiver Operating Characteristic (ROC) curve analysis was utilized to evaluate miR-378's predictive value for coronary stenosis severity.
Datasets
The study utilized data from 215 patients with coronary artery disease (CAD) and 52 healthy control subjects. The primary dataset comprised plasma samples for miRNA analysis and clinical information, including coronary angiography results, collected through a hospital information system. No new benchmarks were introduced.
Key Insights and Ideas
- miR-378 as a potential indicator of disease severity: The study's core insight is the inverse correlation between plasma miR-378 levels and the Gensini score, a measure of coronary artery lesion severity. This suggests that as CAD progresses and lesions become more severe, miR-378 levels decrease.
- Distinguishing CAD patients: The findings indicate that miR-378 can effectively differentiate between individuals with and without coronary artery stenosis, highlighting its potential as a diagnostic tool.
- Non-invasive biomarker potential: The research positions circulating miR-378 as a promising non-invasive biomarker, offering a less invasive alternative to current diagnostic methods.
Key Results
- Down-regulation in CAD: Plasma miR-378 levels were found to be significantly lower in CAD patients compared to healthy controls.
- Correlation with severity: A significant negative correlation (R = -0.4220, P < 0.01) was observed between relative miR-378 levels and the Gensini score, indicating that lower miR-378 is associated with more severe coronary lesions.
- Predictive value: ROC curve analysis showed an Area Under the Curve (AUC) of 0.789 (P < 0.01) for miR-378 in predicting coronary stenosis, suggesting a good predictive capability.
- Independent risk factor: Binary linear regression identified LDL, FBG, and relative miR-378 level as significant factors impacting CAD. Multiple linear regression further indicated that LDL had a significant adverse effect on miR-378 expression.
Limitations and Future Work
The authors acknowledge several limitations. Firstly, the study's sample size, while substantial for a pilot study, could be increased to enhance statistical power, especially given the cost of RT-PCR. Secondly, the study did not directly illustrate the mechanistic link between miR-378, LDL, and CAD, suggesting that further mechanistic studies are needed to confirm its potential as a biomarker. The authors conclude that plasma miR-378 levels appear to be a promising non-invasive biomarker but require further validation in larger cohort studies.
Summary updated